Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
4.280
-0.080 (-1.83%)
At close: Sep 11, 2026, 4:00 PM EDT
4.250
-0.030 (-0.70%)
After-hours: Sep 11, 2026, 7:30 PM EDT
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $348.68 million as of September 11, 2026. Its market cap has increased by 24.18% in one year.
Market Cap
348.68M
Enterprise Value
143.79M
1-Year Change
24.18%
Ranking
Category
Stock Price
$4.28
ChartMarket Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has increased from $271.36M to $348.68M, an increase of 28.50%. That is a compound annual growth rate of 9.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 348.68M | -51.89% |
| Dec 31, 2025 | 724.76M | 232.99% |
| Dec 31, 2024 | 217.65M | -39.13% |
| Dec 29, 2023 | 357.58M | 31.78% |
| Nov 3, 2023 | 271.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Orchestra BioMed Holdings | 367.84M |
| Rocket Pharmaceuticals | 367.74M |
| EyePoint | 364.68M |
| Compass Therapeutics | 360.18M |
| Palisade Bio | 359.00M |
| Sionna Therapeutics | 354.92M |
| DiaMedica Therapeutics | 348.90M |
| X4 Pharmaceuticals | 347.01M |